Selected Publications

Nugent ST, Raj LK, Latif NA, Cory L, Tanyi JL, Kovach SJ 3rd, Fischer JP, Fosnot J, Lin IC, Etzkorn JR, Shin TM, Giordano CN, Higgins HW 2nd, Walker JL, Miller CJ: A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported outcomes. J Am Acad Dermatol Page: S0190-9622(23)00362-6. doi: 10.1016/j.jaad.2023.02.050, Mar 2023.

Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Simpkins F, Morgan MA, Giuntoli RL 2nd: Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma. Gynecol Oncol Page: 169:41-46. doi: 10.1016/j.ygyno.2022.10.025, Feb 2023.

Saris DH, Tubridy E, Gleason E, Breensinger C, Cory L, Latif N, Giuntoli R, Kim SH, Ko EM: Access to Gynecologic Oncologist Specialist Care for Endometrial Cancer Patients in the United States. SGO Winter Feb 2023.

Nasioudis D, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA: Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes. Am J Clin Oncol Page: 45(9):373-378. doi: 10.1097/COC.0000000000000927, Sep 2022.

Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Ko EM: Outcomes of sentinel lymph node mapping for patients with endometrial carcinoma and cervical or extrauterine involvemenet (T2,T3A, or T3B). International Gynecologic Cancer Society Meeting, New York Sep 2022.

Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Simpkins F, Ko EM: Molecular landscape of EBBR2/HER2 gene amplification among patients with endometrial carcinoma” Featured Poster International Gynecologic Cancer Society Meeting, New York Sep 2022.

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Morgan MA, Latif NA: Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database. Gynecol Oncol Page: 166(2):263-268. doi: 10.1016/j.ygyno.2022.05.015, Aug 2022.

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Morgan MA, Latif NA: Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database. Gynecol Oncol 166(2):263-268, Aug 2022.

Nasioudis D, Rush M, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA: Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation. Int J Gynecol Cancer Page: 32(7):823-827. doi: 10.1136/ijgc-2022-003394, Jul 2022.

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA: Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer Page: ijgc-2022-003450. doi: 10.1136/ijgc-2022-003450, Jul 2022.